STOCKSCREENR
Log In

ILMN

NASDAQ

Illumina, Inc.

$120.84+1.56(+1.31%)Mkt Cap: $18.48B

Key Stats

Market Cap

$18.48B

P/E Ratio

22.17

EPS

$5.45

Dividend Yield

0.00%

52-Week Range

$68.70 — $155.53

Volume

1.43M

Avg Volume

2.08M

Beta

1.50

Valuation

P/E (TTM)

22.17

Forward P/E

23.56

PEG Ratio

1.00

P/S (TTM)

4.39

P/B (TTM)

7.00

P/FCF

55.12

EV/EBITDA

47.06x

EV/Sales

—

Financial Health

ROE (TTM)

0.35%

ROA (TTM)

0.13%

ROIC

0.05%

Gross Margin

0.66%

Operating Margin

0.20%

Net Margin

0.14%

Debt/Equity

0.94

Current Ratio

2.08

Growth

EPS Growth (YoY)

-0.78%

Revenue Growth (YoY)

+0.02%

EPS Growth (3Y)

+0.80%

EPS Growth (5Y)

-0.80%

Sales Growth (3Y)

-0.02%

Sales Growth (5Y)

+0.07%

EPS Est (This Year)

$5.13

EPS Est (Next Year)

$5.84

Dividends

Dividend Yield

—

Annual Dividend

—

Payout Ratio

0.00%

Frequency

—

Ex-Dividend Date

—

Cash/Share

$10.67

Analyst Consensus

2.0

Buy

1 = Strong Buy, 5 = Strong Sell

Price Target Range

$110.00$150.00$170.00
LowMedianHigh

Consensus Target: $147.13(21.8% upside)

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

152.90M

Float

148.65M

Free Float %

97.22%

About

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Country

US

Exchange

NASDAQ

IPO Date

2000-07-28

Employees

8970

CEO

Jacob Thaysen

Index Membership

—

Website

https://www.illumina.com

Illumina, Inc. (ILMN) is a healthcare company in the medical - diagnostics & research industry listed on the NASDAQ. With a market capitalization of $18.48B, a P/E ratio of 22.17, ILMN is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare ILMN against other stocks using dozens of fundamental and technical filters.

Similar Stocks

0KHE.L

Revvity, Inc.

$88.87

+3.35%

$9.89B

LH

Labcorp Holdings Inc.

$270.62

+1.41%

$22.43B

NTRA

Natera, Inc.

$198.38

+0.35%

$28.12B

MEDP

Medpace Holdings, Inc.

$455.15

+0.33%

$12.92B

RDNT

RadNet, Inc.

$63.63

-0.73%

$4.94B

0QNO.L

Lonza Group AG

$485.70

+1.19%

$34.00B

Frequently Asked Questions

What is Illumina, Inc.'s P/E ratio?

Illumina, Inc. (ILMN) has a trailing twelve-month (TTM) P/E ratio of 22.17. This is near the market average range. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Illumina, Inc. pay a dividend?

No, Illumina, Inc. (ILMN) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Illumina, Inc.'s market cap?

Illumina, Inc. (ILMN) has a market capitalization of $18.48 billion, classifying it as a large-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.

What do analysts think about ILMN?

Wall Street analysts have a consensus "Buy" rating on Illumina, Inc. (ILMN) with an average score of 2.00 on a 1-5 scale (1 = Strong Buy, 5 = Strong Sell). The consensus price target of $147.13 implies 21.8% upside from the current price.